Category Archives: Meeting Reports

UK-CAB 33 – Meeting report

African Treatment Issues and Late Diagnosis

Issues for African sub-groups
Pre-Meeting for Gilead
Community meeting update from Gilead, Q & A
CROI Feedback

Posted in Meeting Reports | Comments closed

UK-CAB 32 – Meeting report

Advocacy training day

Confidence building workshop
Skill-building session
NHS structures in the UK
Getting other advocates involved
What next – active involvement

Posted in Meeting Reports | Comments closed

UK-CAB 31 – Meeting report

Ageing and HIV

UKCHIC Proposed Ageing Study
Ageing with HIV: Project Overview Will we ever get to be old and wise?
BHIVA Conference overview
Pre-meeting for Abbott
Community Meeting update from Abbott
Community Q & A with Abbott
HIV and Ageing interactive session

Posted in Meeting Reports | Comments closed

UK-CAB 30 – Meeting Full Report

Testing

BHIVA Routine Monitoring Guidelines
HIV Treatment Advocacy Overview
Definitions of Advocacy
Denver Principles
History of Advocacy Film highlights
Advocacy Training in Practice
Pre-Meeting for Bristol-Myers Squibb
Bristol-Myers Squibb Community Meeting, Q&A
Company meeting: BMS
IAS Conference Feedback

Posted in Meeting Reports | Comments closed

UK-CAB 30 – Meeting Summary Report

Testing

BHIVA Routine Monitoring Guidelines
HIV Treatment Advocacy Overview
Definitions of Advocacy
Denver Principles
History of Advocacy Film highlights
Advocacy Training in Practice
Pre-Meeting for Bristol-Myers Squibb
Bristol-Myers Squibb Community Meeting, Q&A
Company meeting: BMS
IAS Conference Feedback

Posted in Meeting Reports | Comments closed

UK-CAB 29 – Meeting report

Resistance Revisited

Introducing the HIV Vaccine Advisory
Board-Ken Legg, MRC and St Marys Hospital
Resistance Explored
Professor Deenan Pillay
Company meeting: GSK abacavir, pipeline drugs and merger

Posted in Meeting Reports | Comments closed

UK-CAB 28 – Meeting report

Late Presenters

BMS/Gilead patient education programme
Training and presentations: Immunology
Company meeting:Tibotec
Etravirine overview including comment on drug interaction,
Darunavir European license extended to all treatment-experienced
Rilpivirine (TMC-278) Next generation first-line NNRTI
and pipeline HIV plus HCV and TB

Posted in Meeting Reports | Comments closed

UK-CAB 27 – Meeting report

Transition from Paediatric Care to Adult Services

Training and presentations: Mexico Feedback. BHIVA Education Scientific Committee Feedback. BHIVHA/CHIVHA Feedback. Update on the HCQ and PIVOT trials.
Transitional Care from Paediatric to Adult Services: A Clinical Care Perspective.
Young People and HIV: A Social Support Perspective

Posted in Meeting Reports | Comments closed

UK-CAB 26 – Meeting Report

TB and HIV — reporting adverse drug reactions — Theratechnologies

Training and presentations: TB and HIV – Yellow Card scheme for reporting adverse drug reactions – feedback from UNGASS, New York and Resistance Workshop, Sitges.
Company meeting: Theratechnologie

Posted in Meeting Reports | Comments closed

UK-CAB 25 – Meeting Report

Reading study results — D:A:D study — BHIVA treatment guidelines — GSK

Training and presentations: Interpreting risk and confidence in study results – D:A:D study: abacavir, ddI and risk of heart attack – conference feedback from CROI 2008.
Company meeting: GlaxoSmithKline – abacavir and data on risk of heart attack, drugs in development.
Community consultation: BHIVA draft treatment guidelines.

Posted in Meeting Reports | Comments closed